Intercept Pharmaceuticals financial update

Intercept shareholders OrbiMed Advisors and Genextra S.p.A. (Milan, Italy) plan to sell 1.5 million shares of Intercept common stock at $62.50 per share. The shareholders expect to receive $93.8 mill...